Milbank Quarterly, August 10, 2015. The House of Representatives did something surprising: They passed a groundbreaking health care law with strong bipartisan support. That sounds like good news. However, this groundbreaking health care law is almost as controversial as the previous one.
Read More »Our Research & Training
We conduct research on the safety and effectiveness of medical products such as Alzheimer’s drugs, cancer drugs, and medical implants and devices used for a wide range of health problems, such as heart disease and joint replacement. In addition to the free information on this website and on www.stopcancerfund.org, we also publish articles in major medical journals and health policy journals.
These are the summaries of studies we’ve done, and here are the articles we’ve published in medical journals and health policy journals in the last few years.
Are you a reporter or medical writer interested in our free Health Research Training Workshop? Learn more here.
Results of NCHR Study of 1104 Women with Essure Problems
September 2015. Report of women who’ve had problems with Essure permanent birth control.
Read More »Essure Permanent Contraception Device: Not So Permanent and Many Side Effects
Contraception, April 2014. Accurate information about how well Essure works and its long-term safety are essential so that women who do not want more children can make an informed choice regarding their contraceptive options.
Read More »Will 20th Century Patient Safeguards Be Reversed in the 21st century?
The BMJ, March 25, 2015. Our new commentary warns of potentially deadly consequences of new legislation to speed the drug approval process while weakening the standards for safety and efficacy.
Read More »Analysis of Impact of Device Excise Tax on U.S.-Based Medical Device Companies
April 16, 2015. The purpose of the 2.3% excise tax on medical devices, which was implemented in January 2013, is to raise revenue to help support health insurance coverage for the millions of Americans who have been unable to afford it.
Read More »